Sceaux, France

Edgar Lederer

This inventor holds 23 USPTO granted patents, primarily in Immunological Adjuvants. Top assignees: Agence Nationale De Valorisation De La Recherche (Anvar), Agence Nationale De Valorisation, Agence Nationale De Valorisation De La Recherche. Active years: 1976-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edgar Lederer. Retrieved from https://idiyas.com/inventor/edgar-lederer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 10

Forward Citations = 255(Granted Patents)


Company Filing History:


Years Active: 1976-1987

Loading Chart...
Areas of Expertise:
Somnogenic Compositions
Muramyl Peptides
Pharmaceutical Compositions
Immunological Agents
Adjuvant Properties
Water Soluble Agents
Peptide Derivatives
Vaccine Adjuvant
Mitogenic Properties
Stabilized Emulsions
Anti-Infectious Agents
Oil-Free Adjuvants
23 patents (USPTO):Explore Patents

Title: Edgar Lederer: A Pioneer in Sleep-Inducing Biological Compositions

Introduction: Edgar Lederer, based in Sceaux, France, is an innovative inventor known for his significant contributions to the field of biological compositions. With a remarkable portfolio of 23 patents, he has made strides in developing compositions that promote sleep and enhance immunological health, showcasing the intersection of science and practical application.

Latest Patents: Among his latest inventions, Lederer has developed somnogenic compositions and methods of use, which are biological compositions designed to induce slow-wave sleep. These compositions comprise biological carriers and sleep-inducing muramyl peptides, including acetylmuramyl-L-alanyl-D-isoglutamine and its derivatives. Another noteworthy patent involves novel compounds of the muramyl peptide, which feature a distinct structure potentially valuable as immunological medicaments. These compounds consist of intricate molecular designs that highlight Lederer's expertise in biotechnology.

Career Highlights: Throughout his career, Edgar Lederer has contributed to prominent organizations, including the Agence Nationale de Valorisation de la Recherche (ANVAR) and the Agence Nationale de Valorisation de la Recherche (ANVAR). His work at these institutions has been instrumental in translating scientific research into actionable innovations, significantly impacting healthcare and therapeutic practices.

Collaborations: Lederer's collaboration with esteemed colleagues such as Louis A. Chedid and Jean Choay has further enhanced his research and development efforts. These partnerships underscore the importance of teamwork in advancing scientific discoveries and creating impactful solutions in the field of biotechnology.

Conclusion: Edgar Lederer's impressive body of work and his 23 patents exemplify his dedication to innovation in biological sciences. His contributions, particularly in sleep-inducing compositions and novel immunological compounds, continue to pave the way for advancements that benefit health and wellness. As he progresses in his career, Lederer remains a significant figure in the realm of scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…